Back
ProShares UltraShort Nasdaq Biotech Vs. SoftBank Group Industry Stock Comparison
Sell
50
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
15.49
Seasonality Move:
-9.57%
Sell
45
SFTBY
SoftBank Group
Last Price:
29.86
Seasonality Move:
0.57%
Sell
50
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $15.45. The Score for BIS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
SoftBank Group (SFTBY)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
- The current SoftBank Group [SFTBY] share price is $29.86. The Score for SFTBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $15.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing slight selling pressure.
SFTBY Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $29.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 56.47 | Buy |
| Chaikin Money Flow: | -1832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.61 - 15.39) | Buy |
| Bollinger Bands (100): | (14.65 - 17.01) | Sell |
SFTBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 53.06 | Buy |
| Chaikin Money Flow: | 400281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.84 - 30.42) | Buy |
| Bollinger Bands (100): | (27.1 - 32.74) | Sell |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.33 | Buy |
| 20-day SMA: | 14.98 | Buy |
| 50-day SMA: | 15.05 | Buy |
| 200-day SMA: | 17.03 | Sell |
| 8-day EMA: | 15.3 | Buy |
| 20-day EMA: | 15.11 | Buy |
| 50-day EMA: | 15.22 | Buy |
| 200-day EMA: | 17.08 | Sell |
SFTBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.89 | Sell |
| 20-day SMA: | 29.58 | Buy |
| 50-day SMA: | 28.51 | Buy |
| 200-day SMA: | 27.85 | Buy |
| 8-day EMA: | 29.75 | Buy |
| 20-day EMA: | 29.52 | Buy |
| 50-day EMA: | 29.38 | Buy |
| 200-day EMA: | 27.81 | Buy |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SoftBank Group Earnings Growth & SFTBY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SoftBank Group Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||